A New Generation of Medicine

Danny graduated from the University of Victoria with a degree in chemistry before becoming an early employee at Aurora Cannabis. His career with Aurora provided foundational experience in enterprise management, good manufacturing practices, and the Controlled Drugs and Substances Act.

Dr. van der Heyden’s scientific focus is on cGMP manufacture of lysergamides, tryptamines and phenethylamines for use in clinical trials, and on biotechnological approaches to assembling precursors and psychedelic drug molecules.

Mark Haden is Adjunct Professor of the UBC School of Population and Public Health. He is currently involved with the British Columbia Health Officers Council drug policy committee and provides public information on drugs and drug policy.

Nadia joined Psygen in February 2020 just prior to the public launch of Psygen Labs. She took an immediate interest in amplifying the company's public dialogue, communications and sales. As the manager of client relations, Nadia is streamlining our psychedelic sales process.

For the last 18 years Nadia has worked on the front lines in EMS. After completing almost 6 years of education, she graduated with a Critical Care Flight Paramedic (CCP) qualification and has worked in emergency retrieval medicine since 2016. Slowing down to a part-time medic she is now focused on work with Psygen.

Bri graduated from the University of Calgary with a BSc in biochemistry and a PhD in physical chemistry. Her R&D experience is diverse with focuses on biomedical device development, petroleum and chemical engineering, agricultural chemical formulation and clean energy process development. Bri’s comprehensive technical, business and research background provide her with the fundamental experience to efficiently and effectively operate the state-of-the-art Psygen laboratory facilities.